에 대한 최신 뉴스 FOXO Technologies (AMEX:FOXO) 주식

FOXO Technologies

FOXO Technologies Inc is a technology platform company focused on commercializing longevity science through products and services that serve the life insurance industry. FOXO's epigenetic technology applies AI to DNA methylation to identify molecular biomarkers of human health and aging. The company has two reportable business segments, FOXO Labs and FOXO Life.

FOXO Technologies Inc. Class A Common Stock

FOXO Technologies Inc

FOXO Technologies Inc Warrants (01/08/2027)

Wells Fargo analyst Michael Turrin maintains Blend Labs (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BLND#NYSE">BLND</a>) with a Overweight and raises the price target from $3.5 to $4.5.

News

Price Target

Analyst Ratings

BLND

Wells Fargo Maintains Overweight on Blend Labs, Raises Price Target to $4.5

Cantor Fitzgerald analyst Kristen Kluska maintains Amicus Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FOLD#NASDAQ">FOLD</a>) with a Overweight and raises the price target from $20 to $21.

FOLD

Cantor Fitzgerald Maintains Overweight on Amicus Therapeutics, Raises Price Target to $21

Keefe, Bruyette &amp; Woods analyst Kyle Voigt maintains MarketAxess Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MKTX#NASDAQ">MKTX</a>) with a Market Perform and raises the price target from $270 to $276.

MKTX

Keefe, Bruyette & Woods Maintains Market Perform on MarketAxess Holdings, Raises Price Target to $276

Wells Fargo analyst Aaron Rakers maintains Qualcomm (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/QCOM#NASDAQ">QCOM</a>) with a Underweight and raises the price target from $170 to $175.

QCOM

Wells Fargo Maintains Underweight on Qualcomm, Raises Price Target to $175

WIIM

Sun Communities shares are trading lower after the company reported worse-than-expected Q3 financial results and cut its FY24 Core FFO below estimates.

Wells Fargo analyst Michael Berg maintains CSG Systems Intl (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CSGS#NASDAQ">CSGS</a>) with a Equal-Weight and raises the price target from $43 to $51.

CSGS

Wells Fargo Maintains Equal-Weight on CSG Systems Intl, Raises Price Target to $51

Keefe, Bruyette &amp; Woods analyst Sanjay Sakhrani maintains Jack Henry &amp; Associates (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/JKHY#NASDAQ">JKHY</a>) with a Market Perform and raises the price target from $180 to $190.

JKHY

Keefe, Bruyette & Woods Maintains Market Perform on Jack Henry & Associates, Raises Price Target to $190

Wells Fargo analyst Michael Berg maintains Freshworks (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FRSH#NASDAQ">FRSH</a>) with a Equal-Weight and raises the price target from $11 to $14.

FRSH

Wells Fargo Maintains Equal-Weight on Freshworks, Raises Price Target to $14

Papa John&#8217;s International, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PZZA#NASDAQ">PZZA</a>) shares <a href="https://www.benzinga.com/movers" target="_blank" rel="noreferrer noopener">are trading lower on Thursday.</a>
The company reported adjusted earnings per share of 43 cents, <a target="_blank" href="https://www.benzinga.com/pressreleases/24/11/b41802404/papa-johns-announces-third-quarter-2024-financial-results" rel="noreferrer noopener">in line with the street view</a>. Quarterly sales of $506.81 million (down 3.1%) beat the analyst consensus estimate of $497.27 million.
&#8220;During the third quarter, we delivered earnings in line with our expectations in what continues to be a very challenging consumer environment,&#8221; said Papa John&#8217;s CEO Todd Penegor.
The lower revenues were mainly due to a $9.9 million decrease in international revenues from UK restaurants, an $8.5 million drop in domestic restaurant sales from lower transaction volumes, and a $4.8 million decrease from the sale of Preferred Marketing, the former print and promotions company.
Also Read: <a target="_blank" href="https://www.benzinga.com/news/earnings/24/11/41808809/wk-kellogg-beats-q3-earnings-estimates-driven-by-strong-pricemix-and-operational-discipline-details" rel="noreferrer noopener">WK Kellogg Beats Q3 Earnings Estimates, Driven By Strong Price/Mix and Operational Discipline: Details</a>
North America comparable sales were down 6% from a year ago. Domestic Company-owned restaurants were down 7%, and North America franchised restaurants were down 5%. International comparable sales were down 3% compared to the previous year.
Adjusted operating income was $29.3 million, a $4.3 million, or 12.9%, decrease from the same period a year ago.
The decrease in adjusted operating income for was mainly due to lower margins at Domestic Company-owned restaurants. This was because the company strategically reinvested some of its first-half savings to improve consumer value perception.
As of Sept. 29, there were 5,908 Papa Johns restaurants operating in 49 countries and territories.
Dividend: On Oct. 29, the firm declared a fourth-quarter dividend of 46 cents per common share. The dividend will be paid on November 29 to stockholders of record as of the close of business on November 18.
In a separate press release, the company announced the appointment of Jenna Bromberg to chief marketing officer, <a href="https://www.benzinga.com/pressreleases/24/11/b41802743/papa-johns-announces-jenna-bromberg-as-chief-marketing-officer" target="_blank" rel="noreferrer noopener">effective Nov. 14.</a>
Price Action: PZZA shares are trading lower by 2.44% to $56.85&nbsp;at last check Thursday.
Also Read:&nbsp;
<ul>
<li><a href="https://www.benzinga.com/news/earnings/24/11/41806970/hersheys-q3-earnings-sour-as-sales-dip-and-outlook-darkens-ceo-pledges-aggressive-turnaround-amid-h" target="_blank" rel="noreferrer noopener">Hershey's Q3 Earnings Sour As Sales Dip And Outlook Darkens; CEO Pledges Aggressive Turnaround Amid High Cocoa Costs</a></li>
</ul>

Earnings

Equities

Guidance

Markets

Movers

General

PZZA

Papa John's Earns Less Dough As Q3 Sales Dip, CEO Blames 'Challenging Consumer Environment'

Keefe, Bruyette &amp; Woods analyst Catherine Mealor maintains Independent Bank Gr (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IBTX#NASDAQ">IBTX</a>) with a Outperform and raises the price target from $69 to $72.

IBTX

Keefe, Bruyette & Woods Maintains Outperform on Independent Bank Gr, Raises Price Target to $72

Duke Energy Says Storm Costs Are Going To Temporarily Impact Our Credit In 2024; Says Expected Revenue Impact Due To Storm Milton Related Outages Will Be Felt In Q4 As Well

Wells Fargo analyst Andrew Bauch maintains AvidXchange Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AVDX#NASDAQ">AVDX</a>) with a Equal-Weight and raises the price target from $9 to $10.

AVDX

Wells Fargo Maintains Equal-Weight on AvidXchange Holdings, Raises Price Target to $10

U.S. stocks traded mostly higher this morning, with the Nasdaq Composite gaining around 1% on Thursday.
Following the market opening Thursday, the Dow traded up 0.06% to 43,757.89 while the NASDAQ rose 1.06% to 19,184.31. The S&amp;P 500 also rose, gaining, 0.52% to 5,959.89.
Check This Out: <a href="https://www.benzinga.com/news/24/11/41801967/top-3-energy-stocks-that-are-ticking-portfolio-bombs">Top 3 Energy Stocks That Are Ticking Portfolio Bombs</a>
Leading and Lagging Sectors Consumer discretionary shares surged by 1.6% on Thursday.
In trading on Thursday, financials shares fell by 0.9%.
Top Headline
The Hershey Company (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HSY#NYSE">HSY</a>) posted weaker-than-expected results for the third quarter on Thursday.
Hershey posted adjusted EPS of $2.34, missing market estimates of $2.56. The company's quarterly sales came in at $2.987 billion versus expectations of $3.077 billion.
Hershey slashed its FY24 adjusted earnings per share view to $9.00 – $9.10 versus $9.40 estimate (from $9.49 – $9.59). The company sees flat net sales in FY24, compared with the prior view of 2% growth.
Equities Trading UP &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<ul>
<li>Webuy Global Ltd (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WBUY#NASDAQ">WBUY</a>) shares shot up 337% to $0.4984.</li>
<li>Shares of Nature&#8217;s Miracle Holding Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NMHI#NASDAQ">NMHI</a>) got a boost, surging 213% to $0.3036. Nature&#8217;s Miracle Holding launched EV business in the U.S. and South America.</li>
<li>AtlasClear Holdings, Inc. &nbsp;(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ATCH#NYSE">ATCH</a>) shares were also up, gaining 57% to $0.2830.</li>
</ul>
Equities Trading DOWN
<ul>
<li>FOXO Technologies Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FOXO#NYSE">FOXO</a>) shares dropped 46% to $0.42.</li>
<li>Shares of Digital Turbine, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/APPS#NASDAQ">APPS</a>) were down 45% to $1.78 after the company reported worse-than-expected second-quarter financial results.</li>
<li>Exela Technologies, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/XELA#NASDAQ">XELA</a>) was down, falling 39% to $1.2099. On Nov. 6, 2024, the Nasdaq Stock Market notified Exela Technologies that the Nasdaq Hearings Panel has determined to delist the company&#8217;s common stock and that trading of the company&#8217;s securities will be suspended at the open of trading on Nov. 8.</li>
</ul>
Commodities In commodity news, oil traded down 0.3% to $71.45 while gold traded up 0.4% at $2,685.80.
Silver traded up 0.6% to $31.505 on Thursday, while copper rose 3.7% to $4.4015.
Euro zone
European shares were higher today. The eurozone's STOXX 600 gained 0.8%, Germany's DAX gained 1.5% and France's CAC 40 rose 0.6%. Spain's IBEX 35 Index rose 0.8%, while London's FTSE 100 rose 0.1%.
The Bank of England cut its Bank Rate by 25bps to 4.75% at its recent meeting. Retail sales in the Eurozone rose 0.5% month-over-month in September versus a revised 1.1% gain in August. The HCOB Eurozone construction PMI climbed to 43.0 in October from 42.1 in the previous month.
The S&amp;P Global France construction PMI climbed to 42.2 in October from 37.9 in the prior month, while German construction PMI declined to 40.2 in October from 41.7 in the previous month.
Asia Pacific Markets
Asian markets closed mixed on Thursday, with Japan's Nikkei 225 falling 0.25%, Hong Kong's Hang Seng Index gaining 2.02%, China's Shanghai Composite Index gaining 2.57% and India's BSE Sensex falling 1.04%.
China&#8217;s trade surplus widened to $95.27 billion in October from $56.13 billion in the year-ago period. Foreign exchange reserves in Singapore increased to SGD 507.6 billion in October from SGD 499.7 billion in the prior month.
Economics
<ul>
<li>U.S. initial jobless claims rose by 3,000 from the previous week to 221,000 in the final week of October, in-line with market expectations.</li>
<li>U.S. nonfarm business sector labor productivity increased by 2.2% in the third quarter compared to a revised 2.1% gain in the prior three-month period.</li>
<li>Unit labor costs in the nonfarm business sector rose an annualized 1.9% during the third quarter compared to a revised 2.4% increase in the earlier period.</li>
</ul>
Now Read This: 
<ul>
<li><a href="https://www.benzinga.com/news/24/11/41805406/wall-streets-most-accurate-analysts-spotlight-on-3-industrials-stocks-with-over-5-dividend-yields">Wall Street&#8217;s Most Accurate Analysts Spotlight On 3 Industrials Stocks With Over 5% Dividend Yields</a></li>
</ul>

Eurozone

Commodities

Intraday Update

Trading Ideas

APPS

ATCH

FOXO

NMHI

WBUY

XELA

Nasdaq Surges 1%; Hershey Posts Downbeat Q3 Results

Keefe, Bruyette &amp; Woods analyst Kyle Voigt maintains Hamilton Lane (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HLNE#NASDAQ">HLNE</a>) with a Market Perform and raises the price target from $181 to $215.

HLNE

Keefe, Bruyette & Woods Maintains Market Perform on Hamilton Lane, Raises Price Target to $215

Cantor Fitzgerald analyst Olivia Brayer maintains Gilead Sciences (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GILD#NASDAQ">GILD</a>) with a Neutral and raises the price target from $70 to $80.

GILD

Cantor Fitzgerald Maintains Neutral on Gilead Sciences, Raises Price Target to $80

Warner Bros. Discovery shares are trading higher after the company reported Q3 earnings.

FAA Administrator Mike Whitaker Spoke With Boeing CEO This Week On 737 Production Plans; Says FAA Will "Further Strengthen And Target Our Oversight" As Boeing Prepares Its Return To 737 Production Plan

Krispy Kreme, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DNUT#NASDAQ">DNUT</a>) shares are <a target="_blank" href="https://www.benzinga.com/movers" rel="noreferrer noopener">trading lower on Thursday.</a>
The company reported third-quarter adjusted earnings per share of a loss of one cent, missing <a href="https://www.benzinga.com/pressreleases/24/11/b41801899/krispy-kreme-reports-third-quarter-2024-financial-results" target="_blank" rel="noreferrer noopener">the analyst consensus of one cent earnings</a>.
Quarterly sales of $379.87 million (down 6.8%) missed the street view of $380.33 million. Krispy Kreme&#8217;s&nbsp;third-quarter&nbsp;results reflect the sale of a majority <a target="_blank" href="https://www.benzinga.com//node/39882974" rel="noreferrer noopener">ownership stake in Insomnia Cookies.&nbsp;</a>
Total company organic revenue increased 3.5% year-over-year, driven by a 15% rise in Delivered Fresh Daily (DFD) and digital sales, which offset softness in U.S. Retail and the U.K.
In the U.S. segment, net revenue fell by 12.2%. This decline was mainly due to a $43.5 million impact from the sale of a majority stake in Insomnia Cookies in July 2024.
In the International segment, net revenue grew by 3.7%, driven by growth in Canada, Japan, and Australia, which offset weaker performance in the U.K.
Also Read: <a target="_blank" href="https://www.benzinga.com/markets/cryptocurrency/24/11/41810728/jpmorgan-predicts-strong-performance-for-bitcoin-and-gold-under-trump-presidency" rel="noreferrer noopener">JPMorgan Predicts Strong Performance For Bitcoin And Gold Under Trump Presidency</a>
Adjusted EBITDA was $34.7 million, down 20.7%, primarily due to the sale of a majority stake in Insomnia Cookies. The adjusted EBITDA margin decreased 160 basis points to 9.1%, impacted by U.K. underperformance and higher vehicle accident claims costs in the U.S.
The company exited the quarter with cash and equivalents worth $25.9 million. Inventories as of quarter-end was $31.49 million. The company&#8217;s long-term debt, less current portion, was $804.64 million.
During the quarter, the company received $117.6 million in net proceeds from the divestiture of Insomnia Cookies and $45.0 million from the repayment of an intercompany loan due from Insomnia Cookies, which was used to reduce long-term debt.
Outlook: Krispy Kreme continues to project FY24 net revenue between $1.65 billion and $1.685 billion, <a target="_blank" href="https://www.benzinga.com/calendars/guidance" rel="noreferrer noopener">compared with the street view of $1.675 billion.</a>
However, the company has revised its adjusted EPS outlook, lowering the <a target="_blank" href="https://www.benzinga.com//node/40246519" rel="noreferrer noopener">range from</a> 24 cents &#8211; 28 cents to 18 cents &#8211; 22 cents, compared to the estimated 25 cents.
Price Action: DNUT shares are trading lower by 5.274% to $11.77 at last check Thursday.
Photo by Alan Budman via Shutterstock
Read Next:
<ul>
<li><a href="https://www.benzinga.com/markets/cryptocurrency/24/11/41782783/coinbase-ceo-brian-armstrong-welcomes-most-pro-crypto-congress-ever-as-end-to-gary-gensler" target="_blank" rel="noreferrer noopener">Coinbase CEO Brian Armstrong Welcomes &#8216;Most Pro-Crypto Congress Ever,&#8217; As End To Gary Gensler&#8217;s SEC Chair Stint Nears</a></li>
</ul>

DNUT

Krispy Kreme Falters In Q3: Earnings Miss, Sales Slide, And Outlook Dims Post-Insomnia Cookies Sale

Keefe, Bruyette &amp; Woods analyst Ryan Tomasello maintains Blend Labs (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BLND#NYSE">BLND</a>) with a Market Perform and raises the price target from $3.25 to $3.85.

Keefe, Bruyette & Woods Maintains Market Perform on Blend Labs, Raises Price Target to $3.85

Cantor Fitzgerald analyst Josh Schimmer reiterates Janux Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/JANX#NASDAQ">JANX</a>) with a Overweight and maintains $100 price target.

Reiteration

JANX

Cantor Fitzgerald Reiterates Overweight on Janux Therapeutics, Maintains $100 Price Target

<a href="https://investorplace.com">InvestorPlace - Stock Market News, Stock Advice &amp; Trading Tips</a>
FOXO Technologies (NYSEMKT:<a href="https://investorplace.com/stock-quotes/foxo-stock-quote/">FOXO</a>) just reported results for the fourth quarter of 2023.<ul><li>FOXO Technologies reported earnings per share of 40 cents.</li><li>The company reported revenue of $110,000.</li></ul><div>InvestorPlace Earnings is a project that leverages data from <a href="https://www.tradesmith.com">TradeSmith</a> to automate coverage of quarterly earnings reports. InvestorPlace Earnings distills key takeaways including earnings per share and revenue, as well as how a company stacks up to analyst estimates. These articles are published without human intervention, allowing us to inform our readers of the latest figures as quickly as possible. To report any concerns or inaccuracies, please contact us at <a href="mailto:editor@investorplace.com">editor@investorplace.com</a>.</div><h3>More From InvestorPlace</h3>
		<ul><li>
						<a href="https://investorplace.com/2023/10/no-1-ai-investment-might-be-this-company-youve-never-heard-of/?cid=MKT764787&amp;eid=MKT802110">The #1 AI Investment Might Be This Company You&rsquo;ve Never Heard Of</a>
					</li>
																<li>
						<a href="https://investorplace.com/2023/07/elon-musks-project-omega-stuns-silicon-valley-insiders/?cid=MKT738510&amp;eid=MKT766411">Musk&rsquo;s &ldquo;Project Omega&rdquo; May Be Set to Mint New Millionaires. Here&rsquo;s How to Get In.</a>
					</li>
																<li>
						<a href="https://investorplace.com/2024/04/legendary-investor-predicts-forget-a-i-this-technology-is-the-future/?cid=MKT794457&amp;eid=MKT802109">Legendary Investor Predicts: &ldquo;Forget A.I. THIS Technology Is the Future&rdquo;</a>
					</li>
									</ul><div>
			<div></div>
						<div></div>
					</div>
	The post <a href="https://investorplace.com/earning-results/2024/06/foxo-stock-earnings-foxo-technologies-for-q4-of-2023/">FOXO Stock Earnings: FOXO Technologies Reported Results for Q4 2023</a> appeared first on <a href="https://investorplace.com">InvestorPlace</a>.

FOXO Stock Earnings: FOXO Technologies Reported Results for Q4 2023

<a href="https://investorplace.com">InvestorPlace - Stock Market News, Stock Advice &amp; Trading Tips</a>
FOXO Technologies (NYSEMKT:<a href="https://investorplace.com/stock-quotes/foxo-stock-quote/">FOXO</a>) just reported results for the first quarter of 2024.<ul><li>FOXO Technologies reported earnings per share of -24 cents.</li><li>The company reported revenue of $7,000.</li></ul><div>InvestorPlace Earnings is a project that leverages data from <a href="https://www.tradesmith.com">TradeSmith</a> to automate coverage of quarterly earnings reports. InvestorPlace Earnings distills key takeaways including earnings per share and revenue, as well as how a company stacks up to analyst estimates. These articles are published without human intervention, allowing us to inform our readers of the latest figures as quickly as possible. To report any concerns or inaccuracies, please contact us at <a href="mailto:editor@investorplace.com">editor@investorplace.com</a>.</div><h3>More From InvestorPlace</h3>
		<ul><li>
						<a href="https://investorplace.com/2023/10/no-1-ai-investment-might-be-this-company-youve-never-heard-of/?cid=MKT764787&amp;eid=MKT802110">The #1 AI Investment Might Be This Company You&rsquo;ve Never Heard Of</a>
					</li>
																<li>
						<a href="https://investorplace.com/2023/07/elon-musks-project-omega-stuns-silicon-valley-insiders/?cid=MKT738510&amp;eid=MKT766411">Musk&rsquo;s &ldquo;Project Omega&rdquo; May Be Set to Mint New Millionaires. Here&rsquo;s How to Get In.</a>
					</li>
																<li>
						<a href="https://investorplace.com/2024/04/legendary-investor-predicts-forget-a-i-this-technology-is-the-future/?cid=MKT794457&amp;eid=MKT802109">Legendary Investor Predicts: &ldquo;Forget A.I. THIS Technology Is the Future&rdquo;</a>
					</li>
									</ul><div>
			<div></div>
						<div></div>
					</div>
	The post <a href="https://investorplace.com/earning-results/2024/06/foxo-stock-earnings-foxo-technologies-for-q1-of-2024/">FOXO Stock Earnings: FOXO Technologies Reported Results for Q1 2024</a> appeared first on <a href="https://investorplace.com">InvestorPlace</a>.

FOXO Stock Earnings: FOXO Technologies Reported Results for Q1 2024

FOXO Technologies regains compliance with SEC reporting requirements

FOXO announces receipt of non-compliance notice with NYSE

An update from FOXO Technologies (FOXO) is now available. FOXO Technologies Inc. has engaged in strategic partnerships and agreements to enhance it...

FOXO Technologies Bolsters Expertise and Leadership Team

FOXO Technologies (FOXO) has shared an update. FOXO Technologies Inc. has engaged in a series of financial agreements with ClearThink Capital Partn...

FOXO Technologies Adjusts Financial Agreements with ClearThink

<a href="https://investorplace.com">InvestorPlace - Stock Market News, Stock Advice &amp; Trading Tips</a>
FOXO Technologies (NYSEMKT:<a href="https://investorplace.com/stock-quotes/foxo-stock-quote/">FOXO</a>) just reported results for the second quarter of 2024.<ul><li>FOXO Technologies reported earnings per share of -24 cents.</li><li>The company reported revenue of $28,000.</li></ul><div>InvestorPlace Earnings is a project that leverages data from <a href="https://www.tradesmith.com">TradeSmith</a> to automate coverage of quarterly earnings reports. InvestorPlace Earnings distills key takeaways including earnings per share and revenue, as well as how a company stacks up to analyst estimates. These articles are published without human intervention, allowing us to inform our readers of the latest figures as quickly as possible. To report any concerns or inaccuracies, please contact us at <a href="mailto:editor@investorplace.com">editor@investorplace.com</a>.</div><h3>More From InvestorPlace</h3>
		<ul><li>
						<a href="https://investorplace.com/2024/04/legendary-investor-predicts-forget-a-i-this-technology-is-the-future/?cid=MKT794457&amp;eid=MKT802109">Legendary Investor Predicts: &ldquo;Forget AI... THIS Technology Is the Future&rdquo;</a>
					</li>
									</ul>The post <a href="https://investorplace.com/earning-results/2024/08/foxo-stock-earnings-foxo-technologies-for-q2-of-2024/">FOXO Stock Earnings: FOXO Technologies Reported Results for Q2 2024</a> appeared first on <a href="https://investorplace.com">InvestorPlace</a>.

FOXO Stock Earnings: FOXO Technologies Reported Results for Q2 2024

FOXO Technologies ( ($FOXO) ) has shared an announcement. Rennova Health, Inc. and its subsidiary engaged in a strategic transaction involving a st...

FOXO Technologies Announces Strategic Transaction and Board Expansion

An update from FOXO Technologies ( ($FOXO) ) is now available. FOXO Technologies, a pioneer in epigenetic biomarker discovery, has had a transforma...

FOXO Technologies Advances in AI-Driven Healthcare Growth

FOXO Technologies ( ($FOXO) ) has provided an announcement. FOXO Technologies Inc. has issued a new Series A Cumulative Convertible Redeemable Pref...

FOXO Technologies Issues New Stock and Negotiates Debt

Press Releases

FOXO Technologies Inc. Announces Receipt of Notice of Non-Compliance  with NYSE Continued Listing Requirements

FOXO Technologies Enters into Share Exchange Agreements to Acquire Healthcare Operations from Rennova Health, Inc.

FOXO Technologies Inc. Announces Receipt of Notice of Non-Compliance with NYSE Continued Listing Requirements; Completes Steps it Believes are Required to Regain Compliance

RENNOVA HEALTH, INC. ANNOUNCES STOCK EXCHANGE AGREEMENTS WITH FOXO TECHNOLOGIES, INC. FOR TWO OPERATING SUBSIDIARIES

FOXO Technologies Inc. Secures Up to $2.8 Million in Senior Notes to Fund Previously Announced Acquisition of Myrtle Recovery Centers, Inc. and Provide Additional Working Capital

Foxo Technologies, Inc., Regains Compliance with SEC Reporting Requirements

FOXO Technologies Inc. Announces Receipt of Notice of Non-Compliance with NYSE Continued Listing Requirements

FOXO Technologies Subsidiary, Myrtle Recovery Centers, Receives Two Full Licenses from the Tennessee Department of Mental Health and Substance Abuse Services

Comments

FOXO Technologies

뉴스

에 대한 최신 뉴스 FOXO Technologies (AMEX:FOXO) 주식

사람들이 또한 지켜본다

뉴스

파트너 / 기고자

벤징가 글로벌